Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Lowengrub

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Neuropharmacology|December 17, 2004
Kleptomania after head trauma: two case reports and combination treatment strategiesAnat Aizer, Katherine Lowengrub, Pinhas N Dannon
The Israel Journal of Psychiatry and Related Sciences|August 17, 2006
Pathological gambling: comorbid psychiatric diagnoses in patients and their familiesPinhas N Dannon, Katherine Lowengrub, Anat Aizer, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Paroxetine in panic disorder: clinical management and long-term follow-upPinhas N Dannon, Katherine Lowengrub, I Iancu, et al.
Expert Review of Neurotherapeutics|February 10, 2006
Current and emerging somatic treatment strategies in psychotic major depressionPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Clinical Neuropharmacology|February 16, 2005
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison studyPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome studyPinhas N Dannon, Katherine Lowengrub, Ernest Musin, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater studyPinhas N Dannon, Katherine Lowengrub, Ernest Musin, et al.
Expert Review of Neurotherapeutics|December 22, 2006
Pharmacotherapy of pathological gambling: review of new treatment modalitiesKatherine Lowengrub, Iulian Iancu, Anat Aizer, et al.
Psychiatry Research|May 18, 2010
Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trialIulian Iancu, Eleonora Tschernihovsky, Ehud Bodner, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|January 25, 2007
Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorderPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Neuropharmacology|December 17, 2004
Kleptomania after head trauma: two case reports and combination treatment strategiesAnat Aizer, Katherine Lowengrub, Pinhas N Dannon
The Israel Journal of Psychiatry and Related Sciences|August 17, 2006
Pathological gambling: comorbid psychiatric diagnoses in patients and their familiesPinhas N Dannon, Katherine Lowengrub, Anat Aizer, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Paroxetine in panic disorder: clinical management and long-term follow-upPinhas N Dannon, Katherine Lowengrub, I Iancu, et al.
Expert Review of Neurotherapeutics|February 10, 2006
Current and emerging somatic treatment strategies in psychotic major depressionPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Clinical Neuropharmacology|February 16, 2005
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison studyPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome studyPinhas N Dannon, Katherine Lowengrub, Ernest Musin, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater studyPinhas N Dannon, Katherine Lowengrub, Ernest Musin, et al.
Expert Review of Neurotherapeutics|December 22, 2006
Pharmacotherapy of pathological gambling: review of new treatment modalitiesKatherine Lowengrub, Iulian Iancu, Anat Aizer, et al.
Psychiatry Research|May 18, 2010
Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trialIulian Iancu, Eleonora Tschernihovsky, Ehud Bodner, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|January 25, 2007
Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorderPinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, et al.
Pageof 2